Medical Market Report

Global Intravenous Membrane Oxygenator Market By Type (Silicon Membrane Oxygenator, and Hole Polypropylene Membrane Oxygenator), By Application (Neonatal Cardiovascular Surgery, and Adult Cardiovascular Surgery), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136682
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Intravenous Membrane Oxygenator Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global intravenous membrane oxygenator market is segmented on the basis of Type, Application, and geography.

    The Worldwide market for Intravenous Membrane Oxygenator Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Intravenous Membrane Oxygenator Market Scope:

    By type, the market is segmented into Silicon Membrane Oxygenator, and Hole Polypropylene Membrane Oxygenator. By Application, the market is divided into Neonatal Cardiovascular Surgery, and Adult Cardiovascular Surgery.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Xenios AG (Germany), Abbott Diabetes Care Inc. (USA), Vital Therapies Inc. (USA), Baxter International Inc. (USA), Asahi Kasei Medical Co. Ltd. (Japan), Medtronic Inc. (USA), Medtronic Inc. (USA), Fresenius Medical Care AG & Co. KGaA (Germany), Thoratec Corp. (USA), Toray Medical Co. Ltd. (Japan), Nikkiso Co. Ltd. (Japan), Nipro Corporation (Japan), SynCardia Systems Inc. (USA), and Terumo Heart Inc. (USA).

    Key Market Segments

    Type

    Silicon Membrane Oxygenator
    Hole Polypropylene Membrane Oxygenator

    Application

    Neonatal Cardiovascular Surgery
    Adult Cardiovascular Surgery

    Key Market Players included in the report:

    Xenios AG (Germany)
    Abbott Diabetes Care Inc. (USA)
    Vital Therapies Inc. (USA)
    Baxter International Inc. (USA)
    Asahi Kasei Medical Co. Ltd. (Japan)
    Medtronic Inc. (USA)
    Medtronic Inc. (USA)
    Fresenius Medical Care AG & Co. KGaA (Germany)
    Thoratec Corp. (USA)
    Toray Medical Co. Ltd. (Japan)
    Nikkiso Co. Ltd. (Japan)
    Nipro Corporation (Japan)
    SynCardia Systems Inc. (USA)
    Terumo Heart Inc. (USA)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Intravenous Membrane Oxygenator Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Intravenous Membrane Oxygenator Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Intravenous Membrane Oxygenator Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Intravenous Membrane Oxygenator Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Intravenous Membrane Oxygenator Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Intravenous Membrane Oxygenator Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Intravenous Membrane Oxygenator sub-markets, depending on key regions (various vital states).
    To analyze Intravenous Membrane Oxygenator Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Intravenous Membrane Oxygenator Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Intravenous Membrane Oxygenator Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Intravenous Membrane Oxygenator Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Intravenous Membrane Oxygenator Market Overview
    

    3.1. Intravenous Membrane Oxygenator Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Intravenous Membrane Oxygenator Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Intravenous Membrane Oxygenator Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Silicon Membrane Oxygenator
    

      4.4. Hole Polypropylene Membrane Oxygenator5. Global Intravenous Membrane Oxygenator Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Intravenous Membrane Oxygenator Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Neonatal Cardiovascular Surgery
    

      5.4. Adult Cardiovascular Surgery6. Global Intravenous Membrane Oxygenator Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Intravenous Membrane Oxygenator Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Intravenous Membrane Oxygenator Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Intravenous Membrane Oxygenator Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Intravenous Membrane Oxygenator Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Intravenous Membrane Oxygenator Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Intravenous Membrane Oxygenator Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Xenios AG (Germany)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Abbott Diabetes Care Inc. (USA)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Vital Therapies Inc. (USA)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Baxter International Inc. (USA)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Asahi Kasei Medical Co. Ltd. (Japan)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Medtronic Inc. (USA)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Medtronic Inc. (USA)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Fresenius Medical Care AG & Co. KGaA (Germany)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Thoratec Corp. (USA)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Toray Medical Co. Ltd. (Japan)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. Nikkiso Co. Ltd. (Japan)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Nipro Corporation (Japan)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. SynCardia Systems Inc. (USA)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments  7.16. Terumo Heart Inc. (USA)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.